| Dr Kimberly Gail Kyker, MD | |
|
100 Healthy Way Ste 1200, Anderson, SC 29621-7916 | |
| (864) 512-6140 | |
| (864) 512-6149 |
| Full Name | Dr Kimberly Gail Kyker |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 100 Healthy Way Ste 1200, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992942502 | NPI | - | NPPES |
| 314083 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abbeville Area Medical Center | Abbeville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
| Edcare Consulting Llc | 5193086833 | 16 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164746392 PECOS PAC ID: 1951215243 Enrollment ID: O20040315000478 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005727 PECOS PAC ID: 1951215243 Enrollment ID: O20040723000885 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Entity Name | Baptist Easley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144452889 PECOS PAC ID: 0840337606 Enrollment ID: O20091027000684 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Entity Name | Edcare Consulting Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053534750 PECOS PAC ID: 5193086833 Enrollment ID: O20180221000847 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Gail Kyker, MD Po Box 100174, Columbia, SC 29202-3174 Ph: (864) 512-7257 | Dr Kimberly Gail Kyker, MD 100 Healthy Way Ste 1200, Anderson, SC 29621-7916 Ph: (864) 512-6140 |
News Archive
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.
Mylan Inc. has announced that its subsidiary, Mylan Pharmaceuticals Inc., received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 10 mg and 20 mg.
The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.
Most emergency department patients want to be involved in some aspects of medical decision-making, but they need to be invited. These are the primary findings of a study to be published in the July 2018 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.
› Verified 9 days ago
Justin M Moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4120 Highway 24, Anderson, SC 29626 Phone: 864-512-5830 Fax: 864-224-4999 | |
Mr. Wajdi Ali Dbouk, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3424 Clemson Blvd, Anderson, SC 29621 Phone: 864-261-4350 Fax: 864-261-4097 | |
Hunter E Woodall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 3700, Anderson, SC 29621 Phone: 864-512-1475 Fax: 864-512-1930 | |
Clifton Wade Straughn, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 Buford Ave, Anderson, SC 29621 Phone: 864-512-5901 Fax: 864-225-1058 | |
David Finney, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Suite 3700, Anderson, SC 29621 Phone: 228-424-7973 | |
Christine Lawrence, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 4144 Clemson Blvd, Anderson, SC 29621 Phone: 864-224-3332 | |
Melody S Franks, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4120 Highway 24, Anderson, SC 29626 Phone: 864-512-5830 Fax: 864-224-4999 |